Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/1999
12/21/1999US6004809 Calcium-independent phospholipase A2
12/21/1999US6004796 Amino acid sequence of enzyme effective in removal of arginine, phenylalanine or methionine from the n-terminal end of peptides in peptide or peptidomimetic synthesis
12/21/1999US6004795 DNA encoding chitin deacetylase preparations
12/21/1999US6004792 Amino acid sequence of enzyme which controls intracellular lipids; for antiinflammatory/antiproliferative/ anticarcinogenic agents; diagnosis and prevention of autoimmune, gastrointestinal, and cardiovascular disorders
12/21/1999US6004791 Amino acid sequence of polypeptide involved in controlling growth factor stimulation of cellular differentiation; for anticarcinogenic agnents and treatment of neural injuries
12/21/1999US6004781 Fusion protein of immunoglobulin heavy chain whose variable region has been replaced by amino acids 1-173 of cd4; viricides for treatment of human immunodeficiency virus and simian immunodeficiency virus; diagnosis/detection
12/21/1999US6004765 Assessment of bone fragility and prediction of osteoporotic fracture risk using a quantitative determination of circulating under-carboxylated osteocalcin
12/21/1999US6004764 Screening methods for potential therapeutic agents which regulate the growth of m. tuberculosis; method for identifying genes of m. tuberculosis which are regulated by a sigma factor of m. tuberculosis
12/21/1999US6004761 Diagnosis and treatment of cancer including malignancies of the breast and lung
12/21/1999US6004562 Outer membrane protein B1 of Moraxella catarrhalis
12/21/1999US6004555 Methods for the specific coagulation of vasculature
12/21/1999US6004554 Methods for targeting the vasculature of solid tumors
12/21/1999US6004553 Inhibitors of tumor necrosis factor receptor associated factor-(traf) mediated signal transduction; use in screening assays and as pharmaceuticals
12/21/1999US6004552 Administration of a monoclonal antibody capable of binding to a human cd40 antigen located on the surface of a human b cell, wherein the binding of the antibody to the cd40 antigen prevents the growth or differentiation of the b cell
12/21/1999US6004548 Polypeptides possessing primary structural conformation and biological properties of mammalian pluripotent granulocyte colony stimulating factor wherein at least one cysteine residue at positions 17,36,42,64,74 is replaced by alanine
12/21/1999US6004535 Methods of imaging neoplastic disease and of detecting and quantifying MN protein/polypeptide using MN-specific antibodies
12/21/1999CA2072891C Pseudomonas exotoxin fusion proteins having carboxyl alterations with increased cytotoxicity
12/21/1999CA2065287C New hcv isolates
12/21/1999CA1340858C Recombinant and native group b eimeria tenella immunogens useful as coccidiosis vaccines
12/19/1999CA2242316A1 Dna encoding a plasminogen activating protein
12/16/1999WO1999064865A1 Assays for tsh receptor autoantibodies
12/16/1999WO1999064629A1 Acrp30r2, a homolog of acrp30 (30 kd adipocyte complement-related protein)
12/16/1999WO1999064627A2 Probes used for genetic profiling
12/16/1999WO1999064626A2 Probes used for genetic profiling
12/16/1999WO1999064608A1 Corin, a serine protease
12/16/1999WO1999064606A1 Tankyrase, a trfi binding protein
12/16/1999WO1999064596A2 Proteins regulating gene expression
12/16/1999WO1999064594A2 Genes and gene expression products that are differentially regulated in prostate cancer
12/16/1999WO1999064593A2 Cell cycle regulation proteins
12/16/1999WO1999064591A1 Antibody against lar phosphatase subunit
12/16/1999WO1999064590A1 Polymorphic markers of prostate carcinoma tumor antigen-1 (pcta-1)
12/16/1999WO1999064589A1 Human receptor tyrosine kinase
12/16/1999WO1999064586A2 Phagocytic assay method
12/16/1999WO1999064584A2 Protein for regulating apoptosis
12/16/1999WO1999064583A2 Compositions and methods for modulating proteolytic degradation of intracellular targets
12/16/1999WO1999064576A2 Human genes differentially expressed in colon cancer
12/16/1999WO1999064564A1 GENES CODING FOR TOMATO β-GALACTOSIDASE POLYPEPTIDES
12/16/1999WO1999064463A1 Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples
12/16/1999WO1999064462A1 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
12/16/1999WO1999064461A2 Monoclonal antibodies, cross-reactive antibodies and method for producing the same
12/16/1999WO1999064460A1 Divalent antibody fragments
12/16/1999WO1999064454A1 Novel nucleolar protein
12/16/1999WO1999064452A1 Gpr35a receptor
12/16/1999WO1999064435A1 The human kidney specific gene kk86
12/16/1999WO1999064073A2 Recombinant immunotoxin directed against the hiv-1 gp120 envelope glycoprotein
12/16/1999WO1999064070A1 Prevention and treatment of sepsis
12/16/1999WO1999064069A1 Antibodies to cytokines in the prevention and treatment of inflammatory bowel disease
12/16/1999WO1999064067A2 Vaccine
12/16/1999WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999WO1999064038A1 Novel analgesic agents
12/16/1999WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064021A1 hCEPR RECEPTOR
12/16/1999WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999WO1999063999A1 H1-histamine receptor antagonists
12/16/1999WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999WO1999054467A9 Sh2 domain-containing peptides
12/16/1999WO1999054354A9 Sp22, a fertility-associated protein from sperm and a method for evaluating and affecting male fertility using it
12/16/1999WO1999046380A3 Human membrane spanning proteins
12/16/1999WO1999043807A3 Human channel-related molecules
12/16/1999WO1999041375A3 Human receptor proteins
12/16/1999WO1999041373A3 Human transport-associated molecules
12/16/1999WO1998024902A8 Adaptor protein frs2 and related products and methods
12/16/1999CA2334745A1 Recombinant immunotoxin directed against the hiv-1 gp120 envelope glycoprotein
12/16/1999CA2334471A1 Antibodies to cytokines in the prevention and treatment of inflammatory bowel disease
12/16/1999CA2332993A1 Phagocytic assay method
12/16/1999CA2331372A1 Tankyrase, a trfi binding protein
12/16/1999CA2330929A1 Probes used for genetic profiling
12/16/1999CA2330238A1 Vaccine
12/16/1999CA2330233A1 Genes coding for tomato .beta.-galactosidase polypeptides
12/16/1999CA2330168A1 Protein for regulating apoptosis
12/16/1999CA2329688A1 Cell cycle regulation proteins
12/16/1999CA2329685A1 Proteins regulating gene expression
12/16/1999CA2328500A1 Polymorphic markers of prostate carcinoma tumor antigen-1 (pcta-1)
12/16/1999CA2328498A1 Monoclonal antibodies, cross-reactive antibodies and method for producing the same____________________________________
12/16/1999CA2321273A1 Novel analgesic agents
12/16/1999CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999CA2319651A1 H1-histamine receptor antagonists
12/16/1999CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999CA2319068A1 Novel angiotensin receptor modulators and their uses
1 ... 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 ... 1494